Health Care [ 3/12 ] | Health Care Providers & Services [ 46/74 ]
NYSE | Common Stock
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services.
Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business.
The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016.
DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 29, 24 | 2.50 Decreased by -4.58% | 2.73 Decreased by -8.42% |
| Aug 6, 24 | 2.50 Increased by +30.89% | 2.54 Decreased by -1.57% |
| May 2, 24 | 2.26 Increased by +80.80% | 1.95 Increased by +15.90% |
| Feb 13, 24 | 1.62 Increased by +174.58% | 1.59 Increased by +1.89% |
| Nov 7, 23 | 2.62 Increased by +131.86% | 2.02 Increased by +29.70% |
| Aug 3, 23 | 1.91 Decreased by -16.96% | 1.69 Increased by +13.02% |
| May 8, 23 | 1.25 Decreased by -22.36% | 1.15 Increased by +8.70% |
| Feb 22, 23 | 0.59 Decreased by -70.79% | 0.91 Decreased by -35.16% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 3.26 B Increased by +4.56% | 214.69 M Decreased by -12.95% | Increased by +6.58% Decreased by -16.75% |
| Jun 30, 24 | 3.19 B Increased by +6.21% | 222.68 M Increased by +24.62% | Increased by +6.99% Increased by +17.33% |
| Mar 31, 24 | 3.07 B Increased by +6.89% | 239.65 M Increased by +40.42% | Increased by +7.80% Increased by +31.37% |
| Dec 31, 23 | 3.15 B Increased by +7.85% | 150.66 M Increased by +33.14% | Increased by +4.79% Increased by +23.45% |
| Sep 30, 23 | 3.12 B Increased by +5.85% | 246.63 M Increased by +49.75% | Increased by +7.90% Increased by +41.47% |
| Jun 30, 23 | 3.00 B Increased by +2.52% | 178.69 M Decreased by -20.51% | Increased by +5.96% Decreased by -22.46% |
| Mar 31, 23 | 2.87 B Increased by +1.96% | 170.67 M Increased by +5.27% | Increased by +5.94% Increased by +3.25% |
| Dec 31, 22 | 2.92 B Decreased by -0.92% | 113.16 M Decreased by -39.64% | Increased by +3.88% Decreased by -39.08% |